Protein critical to early stages of cellular HIV infection identified

August 8, 2017, Tokyo Medical and Dental University
Shortly after HIV-1 entry, MELK produced by the target cell regulates removal of the protein coat (the capsid, CA, which is an important part of the core of the virus) by adding a modification at a specific location. This regulated coat removal promotes optimal production of viral DNA, allowing the infection process to proceed efficiently. Credit: Department of Molecular Virology, TMDU

When a virus enters a cell, one of the first steps in the process of infecting that cell is removal of the protein coat that surrounds the virus's genetic material. The virus can then produce DNA from its own genes and insert it into the cell's genome. This allows the virus to hijack the host cell's machinery, forcing the cell to make copies of the virus.

HIV-1 is the most common form of HIV, the that causes AIDS. Now, a team led by researchers at Tokyo Medical and Dental University (TMDU) have identified a protein produced by the host cell that is necessary for correct removal of the protein coat of HIV-1. The study was published in PLOS Pathogens.

In their search for factors involved in HIV-1 infection, the team interfered with the activity of over 15,000 genes to identify those whose suppression allowed the to survive exposure to the virus. This led them to focus on a protein called maternal embryonic leucine-zipper kinase (MELK).

"Depleting cells of MELK reduced HIV-1 infectivity," lead and corresponding author Hiroaki Takeuchi says. "The virus entered the MELK-depleted cell normally, but its protein coat was not removed correctly so it was unable to efficiently produce DNA from its own . When we restored MELK, the infection process was also restored."

The researchers went on to investigate how MELK interferes with the protein coat removal step of infection. They discovered that MELK alters the coat by attaching a biologically active modification at a specific location. This in turn ensures correct removal of the coat. When the team engineered a mutated version of HIV-1 that was already modified at this location, they found that MELK was no longer needed for coat removal.

"Our results reveal a previously unrecognized mechanism involved in removal of the of HIV-1 and contribute to our understanding of the early stages of the viral life-cycle," corresponding authors Hiroaki Takeuchi and Shoji Yamaoka say. "Furthermore, our findings suggest that MELK is a potential target for anti-HIV-1 therapy."

Explore further: Glioblastoma: Study ties three genes to radiation resistance in recurrent tumors

More information: Hiroaki Takeuchi et al, Phosphorylation of the HIV-1 capsid by MELK triggers uncoating to promote viral cDNA synthesis, PLOS Pathogens (2017). DOI: 10.1371/journal.ppat.1006441

Related Stories

Glioblastoma: Study ties three genes to radiation resistance in recurrent tumors

February 3, 2015
A new study identifies three genes that together enable a lethal form of brain cancer to recur and progress after radiation therapy.

New Ebola study points to potential drug target

April 9, 2015
Opening the door to potential treatments for the deadly Ebola virus, scientists have found that a protein made by the virus plays a role similar to that of a coat-check attendant.

Researchers identify potential Zika virus target

May 4, 2017
New research provides insights into why infection with Zika virus after birth generally causes only mild symptoms, whereas devastating fetal malformations can develop when infection occurs during pregnancy.

Recommended for you

Scientists gain new insight on how antibodies interact with widespread respiratory virus

February 22, 2018
Scientists have found and characterized the activity of four antibodies produced by the human immune system that target an important protein found in respiratory syncytial virus (RSV), according to new research published ...

Study reveals how kidney disease happens

February 22, 2018
Monash researchers have solved a mystery, revealing how certain immune cells work together to instigate autoimmune kidney disease.

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.